Summary. A DNA amplification method was used to detect Myoplasnia pneunioiiiae in clinical samples. M . piiewuoniue 16s ribosomal RNA gene sequences were selected as the amplification target region. The polymerase chain reaction (PCR) with purified DNA fragments as templates yielded an expected 88-bp fragment from M . pt~eunionincr but not from other Mj~~oplustt~ci spp. nor from any of the other bacteria assayed. With this method, the 88-bp product specific for 1M. pneunionicw could be obtained from a minimum of 0.05 pg of M . prieumorziac, DNA. Subsequently this PCR technique was used for the detection of hl.pneurnoniac. in throat-swab samples. Twenty-two of30 culture-positive clinical samples gave positive results in the PCR test. Thirty-two culture-negative clinical samples and 33 samples from healthy volunteers. of which only one was culture-positive, gave negative results in the same PCR test. This PCR method is useful for the direct detection of M . pneumoniae in clinical samples.
Introduction
Mj3copIusrzru pneunioniae is one of the causative agents of primary atypical pneumonia, especially in children and young adults.' ' Epidemic infection with M . pneumoniae tends to occur at intervals of 3-5 years, but most childhood cases are mild. To avoid the unnecessary use of ineffective antibiotics, a rapid method of diagnosis is needed.
Serological methods such as the complement fixation test (CFT)3 and indirect haemagglutination (IHA)' are available for the diagnosis of M . pneunzoniue infection, but these tests are time-consuming, have poor sensitivity and specificity, and diagnosis is oft en retrospective. Recent 1 y , enzyme-li n ked immunosorbent assays (ELISAs) with M . pneumoniae antigen or antibody have been developed5 and a rapid diagnostic method based upon DNA probe technology is also availabk6 These are more specific and sensitive than the seroiogical methods, but the minimum detectable number of cells is thought to be 10"-10" cfu for the DNA probe method, and radioisotope detection is required.
The results of the DNA probe procedure suggested that the polymerase chain reaction (PCR) method might be useful for clinical diagnosis." This method amplifies a specific region of DNA by using two primers and Taq polymerase. Detection of M . pneu- nionicre DNA by PCR has been reported by several groups1I1.le but has not yet been applied to human clinical samples. We report here the detection of M . pneunioniae in clinical throat-swab specimens by a PCK procedure.
Materials and methods

Bacterial strains and grokt7th conditions
M . pneumoniae strains FH and MAC, M. buccale NIH-CH-20247, M . faucium ATCC 2529314, M . .fermentaris fernientans-C, M . genitalium G37, M . hominis PG2 1, M . orale ATCC 15539 and M . salioarium ATCC 14277 were kindly supplied by Dr M. Yoshikawa, The Institute of Medical Science, The University of Tokyo. They were grown on modified Hayflick's medium supplemented with horse serum 10%,l3 except for M . yenitaliurn which was grown on medium supplemented with fetal bovine serum 10%. After incubation for 3-5 days at 37*C, they were subcultured in fresh medium. A diphasic mediuml4> l 5 was used for cultivation of clinical samples to isolate M . pneumoniae. The bacterial strains investigated are listed in table 1.
Clinical samples
The throat-swab samples were obtained from paediatric outpatients presenting with symptoms of cough and fever at several hospitals in Shizuoka prefecture, Japan. Negative control samples were collected from healthy volunteers. Swabs were washed out in 1 ml of PPLO broth by vortex mixing. For detection of M . pneumoniae by cultivation, 0.1 ml of the suspension was inoculated into the diphasic medium and incubated at 37°C for 2-3 weeks. The remainder of the sample was used for DNA extraction.
Extraction of DNA DNA was extracted as described by Stauffer et a1. 16 Briefly, 10 ml of broth-grown mycoplasmas were centrifuged at 15000g for 10min at 4°C and the supernate was discarded. The pellet was suspended in 100 pl of 0.15 M NaCl, 0.1 M EDTA solution, and then 400 pl of lysis solution (0.1 M NaCl; 0.1 M Tris-HC1, pH 8.0; SDS 1 %) was added. The solution was then frozen at -80°C for 10 min, and incubated at 60°C for 5 min after thawing. The lysate was extracted gently, twice, with an equal volume of phenol: chloroform (1 : 1). DNA was incubated at 37°C for 2 h with RNAase A (Sigma) 50pg/ml. The DNA was precipitated with two volumes of ice-cold absolute ethanol, rinsed twice with ethanol 70%, and after drying by evaporation, suspended in 100 pl of TE (10 mM Tris-HC1, pH 8.0; 1 MM EDTA). The concentration of DNA was measured with a spectrophotometer (Beckinan Du-65, Beckman Instruments Inc., Fullerton, USA). For the extraction of bacterial DNA, cells grown in LB broth (Bacto-Trypton 1 O h , yeast extract 1 %, NaCl 0.5%) were harvested by centrifugation at 10000 y for 1 min followed by the same procedure as described above. For throat swabs, the PPLO broth (1 ml) rinse was centrifuged at 15 000 rpm for 10 min at 4"C, and the pellet was suspended in 400 p1 of 15 mM EDTA, 0.1 M NaCl, and vortex mixed. To this was added 50 pl of 0-1 M NaCl, 0-1 M Tris-HC1 (pH 8.0), SDS 8%, and then the solution was frozen. Further extraction was performed as described above. Finally the samples were suspended in 10 pl of TE, and 2 pl of the suspension was subjected to the PCR assay.
DNA amplijication
Oligonucleotide primers were synthesised by a DNA synthesiser (Model 380B, Applied Biosystems Inc., Foster City, USA). Amplifications were performed in a thermal cycler TSR-300 (Iwaki Glass Co., Tokyo, Japan) by the method described by Saiki et al. 17 The PCR reaction mixture consisted of 50p1 of 2 0 0 p~ dNTPs, 5 pl of 10 x Taq polymerase reaction buffer (Stratagene, La Jolla, USA) (100 mM Tris-HC1, pH 8-3 ; 500 mM KCl ; 15 mM MgCl, ; gelatin 0.1 YO w/v and other stabilisers), an appropriate amount (1-10 pl) of template DNA, 1 p~ of each primer, 2.5 units of Taq polymerase (Stratagene), and water. To avoid evaporation, two drops of mineral oil were poured on top of the reaction mixture. The temperature programme was as follows: 94°C for 120 s for initial denaturation, 94°C for 60 s for cycle denaturation, 62°C for 30 s for annealing, 74°C for 30 s for extension. After 35 cycles of incubation, the mixture was incubated at 74°C for 60 s for additional extension. The 10 pl of PCR products were analysed by agarose 4 YO gel electrophoresis in Tris-borate EDTA buffer (Nusieve GTG: Agarose ME = 3: 1) (FMC BioProducts, Rockland, USA). The gel electrophoresis was performed at 100 V for 2-5-3 h. DNA fragments were visualised by UV illumination after staining with ethidium bromide 0.5pg/ml for 30 rnin at room temperature.
Oligonucleotide primers for PCR
Oligonucleotide primers were selected from a variable region of the M . pneumoniae 16s rRNA genome18 as shown in fig. 1 . The sense primer designated Mp-8 consisted of 22 oligonucleotides and the anti-sense primer designated Mp-6 consisted of 26 oligonucleotides. The extra primer, Mp-1, for three-primer 
Three-printer PCR
To confirm that the amplified DNA originated from M . ptieiifi?oniat, three primer PCR was performed as described pre~iously'~ with Mp-8, Mp-6 and Mp-1. When PCR with these three primers produced simultaneous amplification products of 88 bp and 172 bp it could be assumed that these had originated from the target region.
Results
Spec$c.itj. of PCR f o r M. pnownoniuo
No DNA amplification was detected by this method when non-mycoplasma bacterial DNA was examined (data not shown). The results of PCR of eight Mycoplasma species are shown in fig. 2 . The specific 88-bp amplification product was produced from M . pneumoniae strains MAC and FH ( fig. 2, lanes 8 and 9) but not from other Mj.coplustna spp. (fig. 2, lanes 2-7,  10 and 11) . The three-primer method produced two specific bands, 88 and 172 bp, indicating that the 88-bp product of the amplification of Mp-8 and Mp-6 originated from M . pneumoniuo ( fig. 2, lane 12) . A 50-bp fragment sometimes appeared in negative controls. This fragment seemed to be a primer dimer and affected neither the specificity nor the sensitivity of the PCR for M. pneuriioniue.
Semitirity of' PCR .for M . pneuriioriicie
The sensitivity of the PCR method was examined by l l u l r r r r l l . 6. hf h o t i l r n r \ , 7 . M OrLlI': 0. *\I serial dilutions of purified DNA from M . pneumoniae FH (fig. 3) . PCR produced a visible 88-bp fragment from 0.05 pg of template DNA indicating that c. 100 organisms could be detected. When the amplified products were hybridised with a complementary probe, the sensitivity was raised c. 100-fold (data not shown).
. tl c ] r~l
Detection of M . pneumoniae in throat-swab samples bJ* PCR
Seventy-two throat swabs were obtained from patients suspected of having M . pneumoniae infection. Thirty samples were culture-positive for M . pneuwoniue, 32 were negative and 10 gave indeterminate results due to bacterial contamination. In the PCR tests, the 88-bp fragment was produced from 22 of 30 culture-positive samples, two of 32 culture-negative samples and three of 10 contaminated samples (table  11) . In contrast, none of the specimens from healthy controls produced the 88-bp band, although one sample was culture-positive. Representative PCR results are shown in fig. 4 .
Discussion
A PCR procedure was developed for detection of M . pnezmmoniae in clinical throat swabs. Two PCR We applied this PCR method to the detection of M . pneumoniae in clinical specimens. The 88-bp band was amplified with 22 of 30 culture-positive throat samples. It is unclear why eight culture-positive samples did not give a positive PCR result. This may have been due to poor recovery of DNA during the extraction procedure. Two of 32 culture-negative clinical samples gave a positive reaction in PCR, indicating a relatively high specificity of PCR in comparison with cultivation techniques. It is possible that our cultivation technique with a diphasic medium1*-" was not specific for the detection of M . pneumoniae. The cultivation method depends on a colour change due to acid produced by growth of M . pneumoniae, but the growth of contaminating bacteria can also change the colour of the medium. No positive PCR result was obtained with 33 samples from healthy volunteers.
Jensen et a1.I2 used PCR to detect mycoplasmas in simulated clinical samples. Similarly, Bernet et al. used the PCR method for biological samples (throat swabs) obtained from hamsters experimentally infected with M . pneumoniae. The present study is the first to use PCR for the detection of M . pneurnoniae in human clinical samples (throat swabs). The sensitivity and specificity of PCR were estimated to be 73 % and 94 %, respectively. Further evaluation of this PCR method is needed if the test is to be used routinely in clinical practice.
